Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More



Comments (0) | Trackbacks (0) | Permalink

Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: » More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
trauma social network pain medication contract cocaine care coaching drinking nicotine substance use disorder alcohol opiates hydrocodone vivitrol CIWA medical alcoholism primary care methamphetamine over-the-counter substances Raymond Anton PTSD data mining Health Care Utilization OnTrak stimulants SD health insurance OxyContin gabapentin mental illness withdrawal cigarettes psychosocial addiction predictive modeling opiod abuse drug abuse SD members craving score post-traumatic stress disorder chronic pain sober dependence issues drug treatment marijuana Catasys mental health morphine UnitedHealthcare substance dependence randomized oxycodone health insurance relapse prevention hospital Research Across America placebo opioid-drug interactions behavioral health care drug addicts naloxone facebook alcohol dependence medical and behavioral costs painkillers urine drug screen behavioral healthcare prometa relapse Opioid Treatment suboxone pain pills ADHD double-blind stress behavioral health narcotic substance dependence health insurance substance dependence costs addiction treatment Opioid Medications communication buprenorphine bipolar disorder methamphetamine dependence fentanyl opioid antagonist binge drinking codeine physician- patient relations alcohol drinking identification heroin emergency room smoking prescriptions addict medical costs muscle relaxant behavioral healthcare services ER alcohol treatment sugar reduction in craving treatment opioid abuse stratified flumazenil reduction in use Journal of Psychopharmacology pain killers recovery network cocaine treatment opiod-based craving health plan Harold Urschel percocet overdose methadone high-utilizing reducing craving vicodin opioid depression screening opioid overdose drug use health reform diabetes placebo-controlled drug addiction hospitalizations depression ADD sobriety recovery anxiety meth Co Occurring Disorders behavioral health care services
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025